Faculty

Institution

Unit

Venue

David A. Santos

Section Chief of General Surgery

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Head And Neck Surgery

Division Of Surgery

Section Of Hepato-Pancreato-Biliary

Department Of Surgical Oncology

Division Of Surgery

Department Of Surgical Oncology

Department Of Surgical Oncology, Section Of Surgical Endocrinology, United States

Division Of Surgical Oncology

The University of Texas MD Anderson Cancer Center

David A. Santos is currently serving as a Head And Neck Surgery Section Chief of General Surgery at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

David A. Santos

The University of Texas MD Anderson Cancer Center

Section Chief of General Surgery

You can click a keyword to filter the displayed items

oncology medicine lymphoid neoplasia surgery immunology hematology mantle cell lymphoma pharmacology cancer care cancer research clinical trials immunotherapy surgical oncology gastrointestinal surgery clinical research gastroenterology cellular therapy hematological malignancies cancer immunotherapy pharmacotherapy leukemia cancer treatment clinical transplantation laboratory medicine medicinal research digestive endoscopy anti-cancer agents frontline treatment gastrointestinal endoscopy cancer letter clinical mycology general surgery systemic treatment malignant blood disorders young patients medical mycology internal medicine surgical education obesity surgery treatment effects clinical immunology cell therapy endovascular techniques interventional endoscopy robot-assisted surgery interventional endoscopic ultrasound interventional radiology benchmark studies radiation therapy reconstructive surgery 3d reconstruction geriatric medicine therapeutic efficacy retrospective cohort studies cohort studies clinical surgery colorectal cancer liver cancer colorectal surgery hernia surgery non-operative treatment trauma surgery visceral surgery first-line treatment older patients personalized therapy clinical outcomes genomic profiles transformed mcl qualitative review current state robotic retromuscular repairs risk-stratified observation composite chest abdominal wall defect phase ii trial aesthetic plastic surgery plastic surgery translational research thoracic surgery orthopedic surgery arthroplasty anatomical pathology gross anatomy microsurgery pathology outcomes research patient safety anatomy health sciences medical systems aesthetic surgery reconstructive microsurgery cardiothoracic surgery surgical pathology medical education radiation oncology cardiovascular surgery pancreatitis orthopaedic surgery

Notable Scholarly Works

Notable Federal Grants

Collaborators

955 Feasibility and Utility of Intraoperative Ultrasound Versus Standard Intraoperative Cholangiography During Robotic Cholecystectomy in Cancer Patients. Gastrointestinal Endoscopy (2026)

Tca Cycle Mode Switch Determines the Fate of Pirtobrutinib-Tolerant Persister Cells in Mantle Cell Lymphoma. Blood (2025)

pathologycancer cellsoncogeneslymphoid neoplasiacancer researchoncologymantle cell lymphomacellular therapytumor biologypirtobrutinib-tolerant persister cellscell biologyhematological malignancies

Weight-Related Outcomes Among Survivors of Adolescent and Young Adult Cancer After Anti-Obesity Medication Initiation. Journal of Adolescent and Young Adult Oncology (2025)

young adult cancermetabolic complicationspediatric obesityobesity managementhealth sciencesmedicineanti-obesity medication initiationobesityoncologyweight disordersadolescent healthweight-related outcomespublic healthcancer care

Author Correction: Longitudinal Single-Cell Profiling Reveals Molecular Heterogeneity and Tumor-Immune Evolution in Refractory Mantle Cell Lymphoma. Nature Communications (2024)

Shaojun ZhangVivian Changying JiangGuangchun HanDapeng HaoJunwei LianYang LiuQingsong CaiRongjia ZhangJoseph McIntoshRuiping WangMinghao DangEnyu DaiYuanxin WangDavid SantosMaria BadilloAngela LeemingZhihong ChenKimberly HartigJohn BigcalJia ZhouRashmi Kanagal-ShamannaChi Young OkHun LeeRaphael E. SteinerJianhua ZhangXingzhi SongRanjit NairSairah AhmedAlma RodriquezSelvi ThirumurthiPreetesh JainNicolaus Wagner-BartakHolly HillKrystle NomieChristopher FlowersAndrew FutrealLinghua WangMichael Wang

molecular biologysingle-cell analysistumor-immune evolutioncancer research

Evaluating Full Antitumor Activities of Monoclonal Antibody and Innate Immune Cells in Relapsed/Refractory Mantle Cell Lymphoma Using Ex Vivo Organoid Platform. Blood (2024)

cancer immunotherapymalignant blood disordersimmune responsescancer cellsinnate immune cellslymphoid neoplasiacancer lettercellular therapyfull antitumor activitiesimmunologyimmunotherapymedicinal researchcell biologyadult t-cell leukemia-lymphomaexperimental medicinemonoclonal antibodytherapeutic targets

Review of:"[Case Report] Occlusive Syndrome by Internal Transmesosigmoid Hernia: A Case Report and Review of the Literature". (2024)

gastrointestinal surgeryneuropathologyanatomical pathologysurgical pathologyhistopathologydigestive endoscopygastroenterologygross anatomycraniofacial surgerygastrointestinal endoscopymyositisdiagnosismicrosurgerysurgery

Ibrutinib‐Rituximab and Venetoclax (Irv) Followed by Risk‐Stratified R‐Hypercvad/Mtx in Young Patients With Untreated Mantle Cell Lymphoma—Phase‐II Window‐2 Trial. Hematological Oncology (2023)

pathologyclinical trialsmalignant blood disorderslymphoid neoplasiaoncologyhematological malignanciesradiation oncologyleukemiaimmunologyimmunotherapyhematologyjama oncology

Incidence of and Risk Factors for Incisional Hernia After Hepatectomy for Colorectal Liver Metastases. Journal of Gastrointestinal Surgery (2023)

hepatologygastrointestinal surgerygeneral surgeryliver cancergastroenterologyrisk factorshernia surgerysurgical oncologycolorectal liver metastasescolorectal surgerysurgeryincisional hernia

A Prospective Feasibility Study Evaluating the 5X-Multiplier to Standardize Discharge Prescriptions in Cancer Surgery Patients. Surgery Open Science (2022)

Timothy P. DiPeriTimothy E. NewhookRyan W. DayYi-Ju ChiangWhitney L. DewhurstElsa M. ArvideMorgan L. BrunoChristopher P. ScallyChristina L. RolandMatthew H.G. KatzJean-Nicolas VautheyGeorge J. ChangBrian D. BadgwellNancy D. PerrierElizabeth G. GrubbsJeffrey E. LeeChing-Wei D. TzengBrian K. BednarskiIris B. ChenRyan J. ComeauxDana M. CoxBarry W. FeigSarah B. FisherKeith F. FournierSemhar J. GhebremichaelHeather M. GibsonNicole C. GourmelonPaul H. GrahamShannon HancherKelly K. HuntNaruhiko IkomaShanae L. Ivey MPASEmily Z. KeungCelia R. LedetAngela R. LimmerPaul F. MansfieldLauren K. MayonCraig A. MessickKeyuri U. PopatNikita F. Rajkot MPASJustine L. Robinson MPASKristen A. Robinson MPASMiguel A. Rodriguez-BigasDavid A. SantosJohn M. SkibberB. Bryce SpeerJose SolizMatthew M. TillmanKeila E. TorresAntoinette van MeterMarla E. WeldonUduak Ursula WilliamsY. Nancy You

prospective feasibility studyretrospective cohort studiesdischarge prescriptionsveterinary medicinecancer surgery patientssurgerycohort studies

Ibrutinib–Rituximab Followed by R-Hcvad as Frontline Treatment for Young Patients (≤65 Years) With Mantle Cell Lymphoma (Window-1): A Single-Arm, Phase 2 Trial. The Lancet Oncology (2022)

Michael L WangPreetesh JainShuangtao ZhaoHun Ju LeeLoretta NastoupilLuis FayadChi Young OkRashmi Kanagal-ShamannaHolly A HillYixin YaoFredrick B HagemeisterJason R WestinNathan FowlerFelipe SamaniegoRaphael SteinerRanjit NairSwaminathan P IyerLucy NavsariaMaria BadilloLei FengHuang XuelinGraciela M Nogueras GonzalezGuofan XuNicolaus Wagner-BartakSelvi ThirumurthiDavid SantosGuilin TangPei LinSa A WangJeff JorgensenC Cameron YinShaoying LiKeyur P PatelFrancisco VegaL Jeffery MedeirosChristopher R FlowersLinghua Wang

medicineclinical transplantationfrontline treatmentanti-cancer agentsclinical researchcancer researchpharmacologycancer treatmentlymphoid neoplasiaoncologymantle cell lymphomapharmacotherapycellular therapycell therapyyoung patientshematological malignanciescancer careclinical trialsradiation oncologytranslational medicinemedicinal research

1
2
3
4
10 / page

David A. Santos

Section Chief of General Surgery

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Head And Neck Surgery

Division Of Surgery

Section Of Hepato-Pancreato-Biliary

Department Of Surgical Oncology

Division Of Surgery

Department Of Surgical Oncology

Department Of Surgical Oncology, Section Of Surgical Endocrinology, United States

Division Of Surgical Oncology

The University of Texas MD Anderson Cancer Center

David A. Santos is currently serving as a Head And Neck Surgery Section Chief of General Surgery at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

David A. Santos

The University of Texas MD Anderson Cancer Center

Section Chief of General Surgery

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

955 Feasibility and Utility of Intraoperative Ultrasound Versus Standard Intraoperative Cholangiography During Robotic Cholecystectomy in Cancer Patients. Gastrointestinal Endoscopy (2026)

Tca Cycle Mode Switch Determines the Fate of Pirtobrutinib-Tolerant Persister Cells in Mantle Cell Lymphoma. Blood (2025)

pathologycancer cellsoncogeneslymphoid neoplasiacancer researchoncologymantle cell lymphomacellular therapytumor biologypirtobrutinib-tolerant persister cellscell biologyhematological malignancies

Weight-Related Outcomes Among Survivors of Adolescent and Young Adult Cancer After Anti-Obesity Medication Initiation. Journal of Adolescent and Young Adult Oncology (2025)

Author Correction: Longitudinal Single-Cell Profiling Reveals Molecular Heterogeneity and Tumor-Immune Evolution in Refractory Mantle Cell Lymphoma. Nature Communications (2024)

molecular biologysingle-cell analysistumor-immune evolutioncancer research

Evaluating Full Antitumor Activities of Monoclonal Antibody and Innate Immune Cells in Relapsed/Refractory Mantle Cell Lymphoma Using Ex Vivo Organoid Platform. Blood (2024)

Review of:"[Case Report] Occlusive Syndrome by Internal Transmesosigmoid Hernia: A Case Report and Review of the Literature". (2024)

pathologyclinical trialsmalignant blood disorderslymphoid neoplasiaoncologyhematological malignanciesradiation oncologyleukemiaimmunologyimmunotherapyhematologyjama oncology

Incidence of and Risk Factors for Incisional Hernia After Hepatectomy for Colorectal Liver Metastases. Journal of Gastrointestinal Surgery (2023)

hepatologygastrointestinal surgerygeneral surgeryliver cancergastroenterologyrisk factorshernia surgerysurgical oncologycolorectal liver metastasescolorectal surgerysurgeryincisional hernia

A Prospective Feasibility Study Evaluating the 5X-Multiplier to Standardize Discharge Prescriptions in Cancer Surgery Patients. Surgery Open Science (2022)

prospective feasibility studyretrospective cohort studiesdischarge prescriptionsveterinary medicinecancer surgery patientssurgerycohort studies

Ibrutinib–Rituximab Followed by R-Hcvad as Frontline Treatment for Young Patients (≤65 Years) With Mantle Cell Lymphoma (Window-1): A Single-Arm, Phase 2 Trial. The Lancet Oncology (2022)

1
2
3
4
10 / page